Aduro Biotech, Inc. (ADRO): Price and Financial Metrics


Aduro Biotech, Inc. (ADRO)

Today's Latest Price: $0.98 USD

0.01 (-1.01%)

Updated Oct 23 11:45am

Add ADRO to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 329 in Biotech

See all "A" rated Strong Buy stocks

ADRO Stock Summary

  • Aduro Biotech Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 12.83% of US listed stocks.
  • Revenue growth over the past 12 months for Aduro Biotech Inc comes in at -12.9%, a number that bests just 12.99% of the US stocks we're tracking.
  • The volatility of Aduro Biotech Inc's share price is greater than that of 96.21% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Aduro Biotech Inc are SIMO, NTLA, DRNA, SYNA, and ALBO.
  • ADRO's SEC filings can be seen here.. And to visit Aduro Biotech Inc's official web site, go to www.aduro.com.
ADRO Daily Price Range
ADRO 52-Week Price Range

ADRO Stock Price Chart More Charts


ADRO Price/Volume Stats

Current price $0.98
Prev. close $1.00
Day low $0.98
Day high $1.02
50-day MA $1.17
200-day MA $2.46
52-week high $4.93
52-week low $0.92
Volume 90,297
Avg. volume 537,067
Dividend yield N/A
Market Cap 78.54M

Aduro Biotech, Inc. (ADRO) Company Bio


Aduro Biotech is a clinical-stage immuno-oncology company focused on the development of technology platforms to stimulate an immune response against cancer. The company was founded in 2000 and is based in Berkeley, California.





ADRO Latest News Stream


Event/Time News Detail
Loading, please wait...

ADRO Latest Social Stream


Loading social stream, please wait...

View Full ADRO Social Stream

ADRO Price Returns

1-mo -14.04%
3-mo -22.83%
6-mo -73.66%
1-year -77.63%
3-year -92.00%
5-year N/A
YTD -62.88%
2018 -64.80%
2017 -34.21%
2016 -59.49%
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5116 seconds.